Biotechs Stalled Despite Healthcare Rally Merck Gains on New Keytruda Data-More Clinical Trials Underway to Expand Uses Healthcare and Nasdaq stocks caught bids on Monday with the XLV up 0.79%, but biotechs were in the red (IBB) down 0.68 %. Drug distributors and
April 17, 2018